8S33
Malic semialdehyde dehydrogenase (MSA-DH) from Acinetobacter baumannii
8S33 の概要
エントリーDOI | 10.2210/pdb8s33/pdb |
分子名称 | Succinate-semialdehyde dehydrogenase [NAD(P)+], 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID (3 entities in total) |
機能のキーワード | malic semialdehyde, l-carnitine metabolism, nad+, nadp+, l-malate, oxidoreductase |
由来する生物種 | Acinetobacter baumannii |
タンパク質・核酸の鎖数 | 12 |
化学式量合計 | 666861.54 |
構造登録者 | Piskol, F.,Lukat, P.,Blankenfeldt, W.,Jahn, D.,Moser, J. (登録日: 2024-02-19, 公開日: 2024-08-14, 最終更新日: 2024-09-11) |
主引用文献 | Piskol, F.,Lukat, P.,Kaufhold, L.,Heger, A.,Blankenfeldt, W.,Jahn, D.,Moser, J. Biochemical and structural elucidation of the L-carnitine degradation pathway of the human pathogen Acinetobacter baumannii . Front Microbiol, 15:1446595-1446595, 2024 Cited by PubMed Abstract: is an opportunistic human pathogen which can use host-derived L-carnitine as sole carbon and energy source. Recently, an L-carnitine transporter (Aci1347) and a specific monooxygense (CntA/CntB) for the intracellular cleavage of L-carnitine have been characterized. Subsequent conversion of the resulting malic semialdehyde into the central metabolite L-malate was hypothesized. Alternatively, L-carnitine degradation via D-malate with subsequent oxidation into pyruvate was proposed. Here we describe the and reconstitution of the entire pathway, starting from the as yet uncharacterized gene products of the carnitine degradation gene operon. Using recombinantly purified enzymes, enantiomer-specific formation of D-malate by the NAD(P)-dependent malic semialdehyde dehydrogenase (MSA-DH) is demonstrated. The solved X-ray crystal structure of tetrameric MSA-DH reveals the key catalytic residues Cys and Glu, accessible through opposing substrate and cofactor funnels. Specific substrate binding is enabled by Arg, Arg and Ser while dual cofactor specificity for NAD and NADP is mediated by Asn. The subsequent conversion of the unusual D-malate reaction product by an uncharacterized NAD-dependent malate dehydrogenase (MDH) is shown. Tetrameric MDH is a β-decarboxylating dehydrogenase that synthesizes pyruvate. MDH experiments with alternative substrates showed a high degree of substrate specificity. Finally, the entire pathway was heterologously reconstituted, allowing to grow on L-carnitine as a carbon and energy source. Overall, the metabolic conversion of L-carnitine via malic semialdehyde and D-malate into pyruvate, CO and trimethylamine was demonstrated. Trimethylamine is also an important gut microbiota-dependent metabolite that is associated with an increased risk of cardiovascular disease. The pathway reconstitution experiments allowed us to assess the TMA forming capacity of gut microbes which is related to human cardiovascular health. PubMed: 39206375DOI: 10.3389/fmicb.2024.1446595 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.59 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
